Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 27 Issue 12, December 2022

Immunocytochemical co-localization of NR1-immunized (top row) mouse plasma (1:100, green) with a commercial rabbit GluN1-AB (red) in a cell-based (HEK293T) clinical standard assay for NMDAR1-AB (Euroimmun). Double-labeled cells appear yellow (top row, right panel), documenting presence of specific circulating NMDAR1-AB in immunized mice. Plasma (1:100) of OVA-immunized mice (control immunization; bottom row) did not show specific staining for NMDAR1; GluN1/NR1, glutamate ionotropic receptor NMDA type subunit 1; OVA, ovalbumin. Counterstain with DAPI (blue) labelled cell nuclei. For more information see the article by Arinrad et al. on pages 4974–4983.

Image

Top of page ⤴

Comment

  • The brain remains a key reservoir of latent HIV infection, and people living with HIV (PLWH) face a high risk for cognitive impairment and psychiatric disorders. Although the burden of HIV infection and co-morbidities is greatest in the Global South, a large proportion of HIV mental health research is carried out in the Global North. Large, well-funded observational cohort studies exploring HIV-associated psychopathology generally involve participant groups from WEIRD (Western, educated, industrialised, rich and democratic) settings. The socioeconomic status and institutional access afforded to these participant groups on average does not reflect those of the majority of beneficiaries of HIV mental health research. This misalignment may lead to limitations in generalising findings and developing effective interventions to improve the mental health of PLWH. Here, I offer recommendations to actively cultivate authentic diversity and inclusion in the field, with four focus points: (1) for funding bodies, to actively invest in neuroscientists in the Global South for investigations of HIV-related psychopathology; (2) for scientific publishers, to fund professional support services for researchers in the Global South; (3) for academic institutions, to facilitate meaningful, equitable collaborations with researchers in the Global South and incentivise studies with diverse participant groups; and (4) for individual neuroscientists, to actively cite and converse with colleagues in the Global South, tackle personal biases in those conversations, and avoid overgeneralising findings from primarily WEIRD participant groups.

    • Arish Mudra Rakshasa-Loots
    Comment Open Access
Top of page ⤴

Article

Top of page ⤴

Search

Quick links